Experiment 491330

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationMARSHALL,M: MOHLER,J: EDMONDS,K: WILLIAMS,B: BUTLER,K: RYLES,M: WEISS,L: URBAN,D: BUESCHEN,A: MARKIEWICZ,M: CLOUD,G:. (1994). AN UPDATED REVIEW OF THE CLINICAL DEVELOPMENT OF COUMARIN (1,2-BENZOPYRONE) AND 7-HYDROXYCOUMARIN.. 120()
Amount utilized
Compound isolated
DiseaseA PHASE I TRIAL IS NEARING COMPLETION IN WHICH PATIENTS HAVE BEEN TREATED WITH DOSES RANGING FROM 100-7000 MG DAILY.
Dose amountVAR
Number1
Qualitative result.
AnimalHUMAN ADULT
Dose expressionDOSE